1. Home
  2. LGL vs PPCB Comparison

LGL vs PPCB Comparison

Compare LGL & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGL
  • PPCB
  • Stock Information
  • Founded
  • LGL 1917
  • PPCB 2007
  • Country
  • LGL United States
  • PPCB Australia
  • Employees
  • LGL N/A
  • PPCB N/A
  • Industry
  • LGL Industrial Machinery/Components
  • PPCB
  • Sector
  • LGL Technology
  • PPCB
  • Exchange
  • LGL Nasdaq
  • PPCB Nasdaq
  • Market Cap
  • LGL 34.1M
  • PPCB 39.1M
  • IPO Year
  • LGL N/A
  • PPCB N/A
  • Fundamental
  • Price
  • LGL $6.50
  • PPCB $2.22
  • Analyst Decision
  • LGL
  • PPCB
  • Analyst Count
  • LGL 0
  • PPCB 0
  • Target Price
  • LGL N/A
  • PPCB N/A
  • AVG Volume (30 Days)
  • LGL 3.9K
  • PPCB 5.4M
  • Earning Date
  • LGL 11-12-2025
  • PPCB 09-30-2025
  • Dividend Yield
  • LGL N/A
  • PPCB N/A
  • EPS Growth
  • LGL N/A
  • PPCB N/A
  • EPS
  • LGL 0.04
  • PPCB N/A
  • Revenue
  • LGL $4,178,000.00
  • PPCB N/A
  • Revenue This Year
  • LGL N/A
  • PPCB N/A
  • Revenue Next Year
  • LGL N/A
  • PPCB N/A
  • P/E Ratio
  • LGL $161.08
  • PPCB N/A
  • Revenue Growth
  • LGL 6.34
  • PPCB N/A
  • 52 Week Low
  • LGL $5.39
  • PPCB $0.00
  • 52 Week High
  • LGL $9.74
  • PPCB $145.46
  • Technical
  • Relative Strength Index (RSI)
  • LGL 42.55
  • PPCB N/A
  • Support Level
  • LGL $6.52
  • PPCB N/A
  • Resistance Level
  • LGL $6.82
  • PPCB N/A
  • Average True Range (ATR)
  • LGL 0.14
  • PPCB 0.00
  • MACD
  • LGL 0.02
  • PPCB 0.00
  • Stochastic Oscillator
  • LGL 34.69
  • PPCB 0.00

About LGL LGL Group Inc. (The)

LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.

About PPCB Propanc Biopharma Inc.

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

Share on Social Networks: